Purpose and Path

At rngen, we are committed to improving the health of patients of all ages, from newborns to the elderly, by addressing critical gaps in care. Our innovative therapies simultaneously target both inflammation and oxidative stress, key drivers of many chronic and acute diseases. By delivering safer, more effective treatments, we aim to empower healthcare providers and make a lasting impact on global healthcare through cutting-edge science and dedication to patient outcomes.

KYC-A SYSTEMSCHEMICO-PHARMACOLOGY DRUG

KYC targets myeloperoxidase (MPO), an enzyme involved in cell, tissue, and organ damage across numerous diseases. It blocks MPO activity, reducing the production of harmful toxic compounds, and is also transformed into a thiol radical that inhibits enzymes driving inflammation and oxidative stress. This multimodal action defines KYC as a systems chemico-pharmacology agent.

doctor test

DISEASES TREATED

Our therapeutic development program focuses on diseases driven by inflammation and oxidative stress across a variety of tissues and organs. For lung conditions, we are targeting Bronchopulmonary Dysplasia (BPD) and Respiratory Distress Syndrome (RDS). The treatment of blood related conditions include Sickle Cell Disease (SCD). In the brain, we focus on Multiple Sclerosis (MS), Ischemic Stroke, Traumatic Brain Injury (TBI), and Chronic Traumatic Encephalopathy (CTE). Additionally, we are working on treating reperfusion-induced myocardial injury, addressing the damage caused by the initial treatment of heart failure by heart reperfusion.

part of the body brain system

PATIENTS

At rngen, our commitment to patients drives everything we do. We are developing therapies for conditions like Bronchopulmonary Dysplasia (BPD) and Respiratory Distress Syndrome (RDS), which impact the most vulnerable members of our society—premature babies. Our work also addresses diseases such as Sickle Cell Disease (SCD), which disproportionately affects the African American community, along with other heart, lung, brain, and vascular conditions affecting diverse populations. Patients remain at the core of our mission to improve lives.

baby patient
girl patient
boy patient
woman patient
elderly man and doctor

ReNeuroGen LLC is doing business as rngen (DBA: rngen).

OUR BLOG

Explore breakthroughs in neurology, regenerative medicine, and brain health with insights from rngen experts.

man focus of exploring medicine in a computer

The Future of Neurology: Exploring the Role of Regenerative Medicine

Read Here
hand with a artificial brain laser

Understanding the Science Behind Neurogenesis and Brain Health

Read Here
woman treat her brain and monitor it

Innovations in Treating Traumatic Brain Injuries (TBIs): What’s New?

Read Here